NCT03977493View on ClinicalTrials.gov

IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia

PHASE3RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 21, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Focal Hand Dystonia
Interventions
DRUG

Xeomin

One injection of 2.5 to 40 U in each muscle. Injection repeated after 6 weeks if considered necessary

DRUG

Placebo - Concentrate

One injection in each muscle.

Trial Locations (5)

1001

NOT_YET_RECRUITING

Centre hospitalier universitaire vaudois (CHUV), Lausanne

3010

NOT_YET_RECRUITING

Inselspital - University Hospital Berne, Bern

6900

RECRUITING

Neurocentro della Svizzera Italiana, Lugano

8091

NOT_YET_RECRUITING

USZ- Univerity Hospital Zurich, Zurich

9007

NOT_YET_RECRUITING

Neurocenter of St. Gallen, Sankt Gallen

All Listed Sponsors
collaborator

Clinical Trial Unit Ente Ospedaliero Cantonale

OTHER

lead

Alain Kaelin

OTHER